Literature DB >> 2821526

Regional lipiodolized chemotherapy for cholangiocarcinoma associated with oral contraceptives.

J J McAleer1, W Dickey, R Clarke, G W Johnston, M E Callender.   

Abstract

We describe a case of cholangiocarcinoma in a young woman, who presented with cholestatic jaundice following oral contraceptive ingestion. Following diagnostic laparotomy she received intra-arterial 'lipiodolized' chemotherapy. Intravenous mitozantrone was given for 2 years and she is asymptomatic, with computed tomographic evidence of tumour response, 27 months after diagnosis. We suggest that this form of treatment is of value for cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821526      PMCID: PMC2428355          DOI: 10.1136/pgmj.63.741.583

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

Review 2.  Hepatic lesions caused by anabolic and contraceptive steroids.

Authors:  K G Ishak
Journal:  Semin Liver Dis       Date:  1981-05       Impact factor: 6.115

3.  [Primary liver cancer in a woman taking oral contraceptives].

Authors:  H Slaoui; A Vachon
Journal:  Nouv Presse Med       Date:  1980-02-09

4.  Cancer of the liver and the use of oral contraceptives.

Authors:  D Forman; T J Vincent; R Doll
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

5.  Selective effects of Lipiodolized antitumor agents.

Authors:  T Kanematsu; K Inokuchi; K Sugimachi; T Furuta; T Sonoda; S Tamura; K Hasuo
Journal:  J Surg Oncol       Date:  1984-03       Impact factor: 3.454

6.  Biliary carcinoma. A review of 109 cases.

Authors:  F Alexander; R L Rossi; M O'Bryan; U Khettry; J W Braasch; E Watkins
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

7.  Hepatocellular carcinoma and oral contraceptives.

Authors:  B E Henderson; S Preston-Martin; H A Edmondson; R L Peters; M C Pike
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.